COSMOS HEALTH INC. Research and Development Expense
COSMOS HEALTH INC. (COSM) reported Research and Development Expense of $68.55 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-18.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-18
- COSMOS HEALTH INC. research and development expense for the quarter ending 2026-06-30 was $68.55K, a 8.15% decline year-over-year.
- COSMOS HEALTH INC. research and development expense for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- COSMOS HEALTH INC. research and development expense for the quarter ending 2025-12-31 was $410.76K, a 22.98% decline year-over-year.
- COSMOS HEALTH INC. research and development expense for the quarter ending 2025-09-30 was $18.34K.
- COSMOS HEALTH INC. research and development expense for fiscal 2025 was $519.36K, a 2.61% decline from fiscal 2024.
- COSMOS HEALTH INC. research and development expense for fiscal 2024 was $533.29K, a 223.48% increase from fiscal 2023.
- COSMOS HEALTH INC. research and development expense for fiscal 2023 was $164.86K.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $68.55K 10-Q · filed 2026-08-18 | $68.55K 10-Q · filed 2026-08-18 | $479.31K derived: sum of 3 quarters · filed 2026-08-18 | $497.65K derived: sum of 4 quarters · filed 2026-08-18 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-20 | $410.76K derived: sum of 2 quarters · filed 2026-05-20 | $429.10K derived: sum of 3 quarters · filed 2026-05-20 | $503.73K derived: sum of 4 quarters · filed 2026-08-18 |
| 2025-12-31 | $410.76K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $429.10K derived: sum of 2 quarters · filed 2026-04-15 | $503.73K derived: sum of 3 quarters · filed 2026-08-18 | $519.36K 10-K · filed 2026-04-15 |
| 2025-09-30 | $18.34K 10-Q · filed 2025-11-14 | $92.97K derived: sum of 2 quarters · filed 2026-08-18 | $108.60K 10-Q · filed 2025-11-14 | $641.90K derived: sum of 4 quarters · filed 2026-08-18 |
| 2025-06-30 | $74.64K 10-Q · filed 2026-08-18 | $90.27K 10-Q · filed 2026-08-18 | $623.56K derived: sum of 3 quarters · filed 2026-08-18 | $623.56K derived: sum of 4 quarters · filed 2026-08-18 |
| 2025-03-31 | $15.63K 10-Q · filed 2026-05-20 | $548.92K derived: sum of 2 quarters · filed 2026-05-20 | $548.92K derived: sum of 3 quarters · filed 2026-05-20 | $548.92K derived: sum of 4 quarters · filed 2026-05-20 |
| 2024-12-31 | $533.29K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $533.29K derived: sum of 2 quarters · filed 2026-04-15 | $533.29K derived: sum of 3 quarters · filed 2026-04-15 | $533.29K 10-K · filed 2026-04-15 |
| 2024-09-30 | $0.00 10-Q · filed 2025-11-14 | $0.00 derived: sum of 2 quarters · filed 2025-11-14 | $0.00 10-Q · filed 2025-11-14 | |
| 2024-06-30 | $0.00 10-Q · filed 2025-08-18 | $0.00 10-Q · filed 2025-08-18 | ||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-15 | |||
| 2023-12-31 | $164.86K 10-K · filed 2025-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| DataMeds AI, Inc. (MEDS) | United States | $0.011B | |
| NU SKIN ENTERPRISES, INC. (NUS) | United States | $0.225B | -1.18 |
| HERBALIFE LTD. (HLF) | $1.281B | 8.39 | |
| CARDINAL HEALTH INC (CAH) | United States | $51.753B | 29.38 |
| Cencora, Inc. (COR) | United States | $59.130B | 20.57 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |